SEC Form 4 · accession 0001645627-17-000081
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Jun 15, 2017
Accepted (ET)
Jun 19, 2017 · 3:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0574 | A | 21,218,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.055 | A | 21,219,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0569 | A | 21,220,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.057 | A | 21,221,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0518 | A | 21,222,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.052 | A | 21,223,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.052 | A | 21,224,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0566 | A | 21,225,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0566 | A | 21,226,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0558 | A | 21,227,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0563 | A | 21,228,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0558 | A | 21,229,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0553 | A | 21,230,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0539 | A | 21,231,349 | D | |
| Common Stock | Jun 15, 2017 | P | 1,000 | $0.0539 | A | 21,232,349 | D |
Table II — derivative securities
No Table II lines on this filing.